Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Terns discloses new THRB agonists for NASH

March 10, 2020

Indian approval of saroglitazar for noncirrhotic NASH

March 6, 2020

Givlaari receives European approval for Givlaari treatment of AHP in adults and adolescents

March 4, 2020

FDA approves Pizensy for oral solution for chronic idiopathic constipation in adults

March 4, 2020

Dosing begins in phase I study of KAN-101 for the treatment of celiac disease

Feb. 28, 2020

FDA approves Barhemsys for prevention and treatment of PONV

Feb. 27, 2020

Gilead Sciences patents IRAK-4 inhibitors

Feb. 27, 2020

Defibrotide safe in young patients with sickle cell disease undergoing stem cell transplantation

Feb. 26, 2020

Pandion begins first-in-human trial of PT-101 for autoimmune disease

Feb. 26, 2020

Guangzhou Henovcom Bioscience identifies new NR1H4 agonists

Feb. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...